Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tohoku Chemical Co., Ltd. (7446.T)
Hirosaki, JP
Tohoku Chemical Co., Ltd., a Japanese trading enterprise, distributes an extensive array of products, primarily focusing on chemicals, medical supplies, and agricultural provisions. Its core offerings encompass pesticides, food additives, and a variety of industrial chemicals and reagents, along with their corresponding apparatus. In the healthcare sector, the company provides crucial clinical diagnostic reagents and related equipment, such as kits vital for blood and bacterial analysis that aid medical examinations and disease detection. Their medical portfolio further extends to specialized devices like clinical inspection systems and medical imaging equipment, as well as external diagnostic pharmaceuticals and various medical materials. For the food industry, Tohoku Chemical supplies food additives and processing machinery. The company also furnishes a broad spectrum of reagents for quality control, analytical testing, and hygiene applications, including cleaning agents, pesticides, and water treatment solutions. Additionally, they offer essential materials for research and development, encompassing transfer, analytical inspection, and new product innovation. Within agriculture, their provisions include pesticides, soil conditioning agents, and other farming requisites, alongside agricultural infrastructure like steel greenhouses designed for floriculture. They also market general wellness and healthcare items. Beyond these specialized areas, Tohoku Chemical Co., Ltd. is involved in the sales and maintenance of computing devices, scientific instruments, medical and educational apparatus, and measuring equipment. Furthermore, the company cultivates and sells flowers. Established in 1953, the firm maintains its headquarters in Hirosaki, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.11% | +0.44% | +5.14% | -4.17% | +20.58% | +20.58% | +16.90% | +29.58% | +36.09% | +80.75% | +104.44% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+7.1% ★ Q1'26: +13.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+80.6% ★ Q1'26: +12.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.2% Q1'26: +1.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+1.5% Q1'26: +2.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.4% Q1'26: +13.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.19× ★ Q1'26: 0.77× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Makoto Ono | Managing Director | — | — |
| Wataru Nishibori | Head of Industry Sales Group, Sales Promotion Office, Managing Executive Officer & Director | — | male |
| Yasuo Azuma | Executive Chairman of the Board | — | male |
| Yasuyuki Azuma | President & Chief Executive Officer and Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7446.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
